Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

US and Canada

This page shows the latest US and Canada news and features for those working in and with pharma, biotech and healthcare.

GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis

GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis

GSK’s Benlysta (belimumab) has been given Orphan Drug Designation (ODD) by the US Food and Drug Administration for the potential treatment of systemic sclerosis (SSc), the company announced. ... It is already approved in the US, the EU and Canada to

Latest news

More from news
Approximately 0 fully matching, plus 331 partially matching documents found.

Latest Intelligence

  • Envisioning a healthier every day, for every woman Envisioning a healthier every day, for every woman

    known as Merck &Co in the US and Canada) with a mission to create improved health outcomes for women around the world. ... Led by a majority female leadership team, Organon’s leaders drive our commitment to women’s health and inspire us to do more

  • Surviving cancer: a new era for patients Surviving cancer: a new era for patients

    it was reported that five-year cancer survival rates are increasing globally, with the US, Canada and Australia among the highest. ... a terminal disease, and more towards helping cancer patients manage their condition effectively.

  • Health trust in a COVID-19 world – a unique opportunity for pharma Health trust in a COVID-19 world – a unique opportunity for pharma

    There are notable increases in ten of the 11 markets included in the Trust Barometer Spring Update, with the largest gains in trust seen in Canada, Germany and the US. ... This sub-sector had the highest increase in trust globally and, mirroring the

  • GSK forges ahead with its dynamic COPD and asthma portfolio GSK forges ahead with its dynamic COPD and asthma portfolio

    doing very well and you can also identify patients with ongoing, unmet need. ... For instance, in the UK, US, Canada and Spain, the first treatment was an ICS/LABA, such Seretide or Symbicort, while in Germany it was a bronchodilator.

  • Deal Watch October 2018

    US. US and Canada only. # US and EU. Roche’s collaboration with Ionis Pharmaceuticals has a headline of $760m, $1m more than the Tusk deal. ... milestones and royalties, and US profits or losses will be split 50:50.

More from intelligence
Approximately 0 fully matching, plus 40 partially matching documents found.

Latest appointments

  • EFPIA appoints Hubertus von Baumbach as president EFPIA appoints Hubertus von Baumbach as president

    Baumbach had been a member of Boehringer’s board of managing directors since 2009, and he has also previously worked at Roche in the US and for Boehringer in Canada. ... that the EU remains an innovation leader and to build a healthier future for

  • Merck & Co appoints Frank Clyburn as president, human health Merck & Co appoints Frank Clyburn as president, human health

    Merck &Co – known as MSD outside the US and Canada – has appointed Frank Clyburn (pictured above) as president, human health. ... Clyburn joined Merck &Co in 2008 and during his time with the company, he has had responsibility for various global

  • McCann Health North America appoints Jim Joseph as president McCann Health North America appoints Jim Joseph as president

    Joseph will oversee all North American advertising and promotion agencies in the US and Canada. ... In his new role at McCann Health, he will oversee all North American advertising and promotion agencies in the US and Canada, and will build and expand

  • NDA bolsters its senior team NDA bolsters its senior team

    US, Europe, Canada and other markets. ... Her contributions will help propel client strategy and accelerate programmes across the EU and US, as well as result in new intriguing service offerings that enable innovative companies to navigate the

  • Celgene’s president and COO to retire Celgene’s president and COO to retire

    Smith has over 30 years of business strategy experience across a range of therapeutic areas, having previously held senior leadership roles at Biovail in Canada, France, the US and Hong Kong, ... Smith's successor, Curran, joined Celgene in 2013 as the

More from appointments
Approximately 0 fully matching, plus 19 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...

Quick links